Related Experiment Videos
[Severe alpha 1-antitrypsin deficiency: cross sectional clinical study]
1Spedali Civili e Cattedra di Medicina Interna, Università degli Studi di Brescia. corda@master.cci.unibs.it
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|August 2, 2000
Summary
Severe alpha 1-antitrypsin deficiency (AATD) significantly impairs lung function, especially in symptomatic individuals. Smoking acts as a key cofactor, exacerbating emphysema development in AATD patients.
Area of Science:
- Pulmonology
- Genetics
- Internal Medicine
Context:
- Alpha 1-antitrypsin deficiency (AATD) is an underdiagnosed genetic disorder.
- Severe AATD significantly increases the risk of developing pulmonary emphysema and liver disease.
- Understanding the clinical presentation and risk factors is crucial for early diagnosis and management.
Purpose:
- To investigate the clinical characteristics and pulmonary function of severe alpha 1-antitrypsin deficient subjects.
- To compare symptomatic (Index Cases) and asymptomatic (Non-Index Cases) individuals with severe AATD.
- To identify potential cofactors contributing to disease progression, such as smoking.
Summary:
- Twenty subjects with severe AATD were studied, divided into symptomatic Index Cases (n=7) and asymptomatic Non-Index Cases (n=13).
- Index Cases, predominantly ZZ phenotype, showed significant pulmonary impairment compared to Non-Index Cases.
- Smoking was identified as a potential cofactor, with a higher prevalence in Index Cases and correlating with emphysema development.
Impact:
- Highlights the significant lung function deficits in symptomatic severe AATD patients.
- Emphasizes the role of smoking as a critical cofactor in emphysema development in AATD.
- Underscores the need for increased awareness and improved diagnostic strategies for this underdiagnosed condition.